Pharmaceutical Affairs Act Article 96-1

Any pharmaceutical firm that violates any one of the provisions under Article 48-1 shall be subject to a fine of no less than NT$100,000 but not more than NT$2,000,000. In the case that improvement is not made within the time limit notified by the competent health authority, said pharmaceutical firm shall be subject to a fine of double the amount and shall be fined consecutively until improvements have been made.Where a pharmaceutical firm fails to make the report required under Article 27-2, Paragraph 1, files a false report, or fails to make the notification within the time limit prescribed in Paragraph 2 of the same Article, the central competent health authority may make a public announcement of the name of the firm, address, name of the responsible person, name of the drug, and the violation detail. In the case of a serious violation or repeated violation, said pharmaceutical firm may be imposed with a fine of not less than NT$60,000 but not more than NT$300,000.Where a pharmaceutical firm violates the restrictive measures imposed by the central competent health authority pursuant to Article 27-3, Paragraph 2, the central competent health authority shall impose a fine of not less than NT$60,000 but not more than NT$300,000, and order the firm to make improvements within a prescribed time limit. Failure to make improvements within the time limit shall be fined consecutively.